Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides

Table 1 Demographic and clinical characteristics of participants

Variable	Non-obese low depressive^a	Obese low depressive^b	Non-obese high depressive^c	Obese high depressive^d
Age	39 ± 12.2	38.9 ± 17.2	42.7 ± 10.5	43.5 ± 10.9
Sex (%female)	44	50	61.1	73.3
Race(%C/AA/Asn/NS)	72/16/12/0	37.5/37.5/12.5/12.5	55.6/16.7/27.8/0	46.7/40/13.3/0
BARIC	32.1 ± 10.2^d	21.9 ± 6.2^c	31.8 ± 9^cd	25.3 ± 7.5^ac
BMI (kg/m2)	25.1 ± 2.9^bd	35.5 ± 4.7^ac	26.6 ± 2.9^bd	36 ± 4.7^ac
BDI-T	0.5 ± 0.8^cd	0.6 ± 0.7^cd	7.9 ± 5.4^ab	7.9 ± 5^ab

Values presented as mean ± SD. Significant differences between groups were evaluated by Mann-Whitney test and presented as superscripts
Abbreviations: C Caucasian, AA African-American, Asn Asian, NS Mixed or not specified, BARIC Monocyte beta-adrenergic receptor-mediated inflammation control, BMI Body mass index, BDI-T Beck Depression Inventory (BDI-Ia) total score

ISSN: 1471-2180